About F-star Therapeutics, Inc. (FSTX) — Dividend Analysis 2026
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Is FSTX a good dividend investment in 2026?
FSTX offers a 28.09% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
FSTX DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your FSTX portfolio grows to $118.9K vs $38.1K without reinvestment. This is the compound interest effect in action.
FSTX dividend growth history & forecast
FSTX has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 28.09%.
Company generates negative FCF ($-28M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
0 / 30 pts
0/30
Company is reporting net losses — dividend sustainability is in question
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
0
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 FSTX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold FSTX.
Gross yield
28.09%
Tax rate
15.00%
After-tax yield
23.88%
Real yield (−CPI)
21.08%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
28.09%
25.29%
$2,809 / yr
🇺🇸 US Taxable (15%) ✓
15%
23.88%
21.08%
$2,388 / yr
🇺🇸 US Taxable (20%)
20%
22.47%
19.67%
$2,247 / yr
🇬🇧 UK ISA
0%
28.09%
25.29%
$2,809 / yr
🇬🇧 UK Taxable
8.75%
25.63%
22.83%
$2,563 / yr
🇨🇦 TFSA
0%
28.09%
25.29%
$2,809 / yr
🇨🇦 CA Taxable
25%
21.07%
18.27%
$2,107 / yr
🇦🇺 Super (pension)
15%
23.88%
21.08%
$2,388 / yr
🇦🇺 AU Taxable
30%
19.66%
16.86%
$1,966 / yr
🇩🇪 DE Taxable
26.375%
20.68%
17.88%
$2,068 / yr
🇫🇷 FR Taxable
30%
19.66%
16.86%
$1,966 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 FSTX Income Goal & Break-Even
Dividend Break-Even
5yr
Years for dividends to fully repay your FSTX investment of $7.12/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$75.1K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$72.6K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in FSTX for:
Shares needed
14,118
Capital required
$100,520
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 FSTX Dividend Payment Schedule
FSTX pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 FSTX vs Healthcare Benchmarks
How FSTX compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+25.29% vs sectorBetter
FSTX
28.09%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
FSTX
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
FSTX
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for FSTX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ FSTX Insider Activity
No recent SEC filings reported in the last 90 days.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the FSTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →